-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
781 drugs withdrew from the procurement platform, involving multiple varieties such as pediatric paracetamol Huangnamin granules, emergency branch syrup, and cefadroxil tablets
781 drugs withdrawn from the procurement platform
781 drugs withdrawn from the procurement platformA few days ago, the Heilongjiang Provincial Medical Insurance Bureau issued the "Notice on the withdrawal of some drugs from the provincial procurement platform" (hereinafter referred to as the "Notice"), involving 781 drugs and 167 companies
According to the "Notice", a total of 781 drugs have been withdrawn from the procurement platform of Heilongjiang Province this time, including many commonly used drugs such as Pediatric Paracetamol Huangnamin Granules, Ganmaokang Capsules, Xinkeshu Capsules, Jizhi Syrup, and Cefadroxil Tablets
As for the reasons for withdrawing from the provincial procurement platform, it mainly involves many aspects, including rising costs and inability to supply at current prices; suspension of production; adjustment of production lines; price inversion; raw material problems and inability to produce.
Price is the main reason for withdrawal
Price is the main reason for withdrawalAmong the 781 drugs that were withdrawn from the network this time, "increased production costs, unable to be supplied at current prices" and "stop production" were the main reasons for the withdrawal.
For example, the reference price of Xinkeshu Capsules produced by Chongqing Xier'an Pharmaceutical Co.
The net reference price of nifedipine tablets produced by Guangdong Huanan Pharmaceutical Group Co.
Guangzhou Baiyunshan Zhongyi Pharmaceutical Co.
In addition, there is also a price-related exit reason-because the company can lower the price as required, the non-selected drug price linkage declaration in Heilongjiang Province did not declare it
For example, prucalopride succinate, a subsidiary of Johnson & Johnson subsidiary Xi'an Janssen, has a reference price of 12.
Escitalopram oxalate tablets produced by Danish Lundbeck Pharmaceuticals and subpackaged by Xi'an Janssen Pharmaceuticals also withdrew because they did not reduce their prices as required
A large number of drugs are discontinued
A large number of drugs are discontinued"Suspension of production" is the second largest reason for withdrawal of the network after "cost increase".
For example, Renhetang Pharmaceutical Co.
In addition, the Naozhenning granules of Shanxi Zhendong Ante Biopharmaceutical Co.